Objective Assessment of the Long-Term Volumizing Action of a Polycaprolactone-Based Filler
- PMID: 36597519
- PMCID: PMC9805706
- DOI: 10.2147/CCID.S385202
Objective Assessment of the Long-Term Volumizing Action of a Polycaprolactone-Based Filler
Abstract
Background: The polycaprolactone-based filler, (PCL-1, Ellansé-S), forms part of the recently growing portfolio of biodegradable collagen-stimulating fillers. It is comprised of a suspension of 25-50 micron diameter microspheres of polycaprolactone (PCL) (30%) in a carboxymethyl cellulose (CMC) gel carrier (70%) and has gained popularity due to its long-term volumizing action.
Objective: This study outlines a retrospective case series of nine patients injected with the PCL-1, for volume augmentation in the mid-face. Objective volume calculations were performed with the Canfield Vectra 3D Imaging System at two time points post-implantation, with the objective of determining the longevity of the volumizing effect of the bio-stimulating substance.
Results: A clear increase in volume, between 50-150%, was found in all of the patients at two years, over and above the volume initially injected. All the patients were satisfied with the longevity of the results.
Discussion: The PCL-based filler is believed to afford immediate volume restoration due to the CMC gel component and a long-term action due to neo-collagenesis, induced by the PCL microspheres. The CMC gel is known to dissipate within 6-8 weeks, only to be replaced by new collagen induced by the PCL particles. Thus soft-tissue formation induced by the PCL particles, ultimately leads to a sustained volumizing effect.
Conclusion: The PCL-based filler is shown to have a sustained volumizing effects of at least 2 years duration with clear evidence of increase in volume over and above the volume injected, in all of the cases studied. This is indicative of significant neo-collagenesis induced by the PCL microspheres.
Keywords: Vectra 3D; biostimulant; polycaprolactone.
© 2022 Angelo-Khattar.
Conflict of interest statement
The author reports no conflicts of interest in this work.
Figures
References
-
- American Society of Plastic Surgeons (ASPS). Plastic surgery statis- tics report; 2020. Available from: https://www.plasticsurgery.org/documents/News/Statistics/2020/plastic-su.... Accessed November 1, 2022.
-
- Keen MA. Hyaluronic acid in dermatology. Skinmed. 2017;15(6):441–448. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
